Clinical Trial Update: A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of AMB-05X injections in Pigmented Villonodular Synovitis and Tenosynovial Giant Cell Tumor has completed. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pigmented Villonodular Synovitis
• Tenosynovial Giant Cell Tumor

Drugs mentioned

• AMB-05X

Snippet

Sponsor: AmMax Bio, Inc. | Conditions: Pigmented Villonodular Synovitis, TGCT | Phase 2 | Status: COMPLETED